Details of the Drug

General Information of Drug (ID: DM7D4EP)

Drug Name
RHIgM22
Indication
Disease Entry ICD 11 Status REF
Multiple sclerosis 8A40 Phase 1 [1]
Cross-matching ID
TTD ID
D03YGL

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)